Pharminent

FDA Approves Once-Daily QTERN® (Dapagliflozin and Saxagliptin) Tablets for Adults with Type-2 Diabetes

[Business Wire] – AstraZeneca today announced that the US Food and Drug Administration has approved once-daily QTERN® for the treatment of type-2 diabetes. http://finance.yahoo.com/news/fda-approves-once-daily-qtern-071000839.html

Filed under: Diabetes